Loading
A phase 2 trial of camrelizumab in colorectal cancer, run by The Fourth Affiliated Hospital of Zhejiang University School of Medicine, not yet recruiting.
A Clinical Study on the Treatment of Metastatic Colorectal Cancer at the Second-line or Beyond. is a phase 2, interventional study registered as NCT07395063 by The Fourth Affiliated Hospital of Zhejiang University School of Medicine, with a registry enrolment figure of 68 participants, started 2026-02-01 and due to reach its primary completion in 2029-02-01. Interventions recorded: Irinotecan liposome combined with capecitabine, bevacizumab and camrelizumab. Conditions listed: Metastatic Colorectal Cancer (CRC). Primary outcome: Progression-free survival (PFS）. Colorectal eligibility wording from the registry: "* Patients pathologically diagnosed with colorectal cancer;". No results are recorded here; the registry entry is the source.
Shares Camrelizumab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Camrelizumab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Camrelizumab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Camrelizumab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.